Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-087354
Filing Date
2025-06-17
Accepted
2025-06-17 16:08:49
Documents
2
Period of Report
2025-06-15

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4773
2 EX-24.1 aplt-ex24_1.htm EX-24.1 12776
  Complete submission text file 0000950170-25-087354.txt   19095
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Issuer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O APPLIED THERAPEUTICS, INC. 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address
Bailey Evan Prescott (Reporting) CIK: 0002071667 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38898 | Film No.: 251053389